Moderna, Inc. (MRNA) vs Vertex Pharmaceuticals Incorporated (VRTX)
- Moderna, Inc. MRNA 255.51 +5.82%
- Vertex Pharmaceuticals Incorporated VRTX 547.08 +0.84%
Moderna, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $137.5B against $96.4B — 1.4× the size. Moderna, Inc. has negative trailing earnings, so its P/E is not meaningful; Vertex Pharmaceuticals Incorporated trades at 34.6×. Vertex Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 10.5% against −27.6%. Vertex Pharmaceuticals Incorporated has the higher net margin (30.7% vs −141.4%) and the higher return on invested capital (14.9% vs −93.5%). Across the 19 metrics below, Vertex Pharmaceuticals Incorporated leads on 17 and Moderna, Inc. on 2.
Valuation
Profitability
| Metric | MRNA | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 23.38% | 85.53% | 65.16% |
| Operating margin | (149.01%) | 33.23% | 0.00% |
| Net margin | (141.43%) | 30.70% | 0.00% |
| Free cash flow margin | (55.83%) | 24.73% | 0.00% |
| Return on equity | (39.00%) | 20.80% | (50.12%) |
| Return on assets | (27.43%) | 13.81% | (45.60%) |
| Return on invested capital | (93.47%) | 14.86% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack